-
Product Insights
NewPhosphodiesterase 10 – Drugs In Development, 2024
The Phosphodiesterase 10 pipeline drugs market research report outlays comprehensive information on the Phosphodiesterase 10 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Oncology, Genetic Disorders, and Gastrointestinal which include indications of Schizophrenia, Tourette Syndrome, Lung Cancer, Solid Tumor, Fragile X Syndrome, Prader-Willi Syndrome (PWS), and Ulcerative Colitis. It also reviews key players involved...
-
Product Insights
NewInterleukin 10 – Drugs In Development, 2024
The Interleukin 10 pipeline drugs market research report outlays comprehensive information on the Interleukin 10 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Gastrointestinal, Immunology, and Oncology which include indications of Multiple Sclerosis, Neuropathic Pain (Neuralgia), Ulcerative Colitis, Crohn's Disease (Regional Enteritis), Rheumatoid Arthritis, Inflammation, Solid Tumor, and Renal Cell Carcinoma. It also reviews...
-
Product Insights
NewInterleukin 10 Receptor – Drugs In Development, 2024
The Interleukin 10 Receptor pipeline drugs market research report outlays comprehensive information on the Interleukin 10 Receptor targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Immunology, Central Nervous System, and Gastrointestinal which include indications of Colorectal Cancer, Head And Neck Cancer, Autoimmune Disorders, Rheumatoid Arthritis, Neuropathic Pain (Neuralgia), Inflammatory Pain, and Inflammatory Bowel Disease. It also...
-
Product Insights
NewSA-10 Upstream Project , Croatia
Empower your strategies with our SA-10 Upstream Project , Croatia report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain a gateway to actionable insights and competitive advantage. Acquire a thorough understanding of...
-
Product Insights
NewKenli 10-2 Upstream Project , China
Empower your strategies with our Kenli 10-2 Upstream Project , China report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons to buy Gain a gateway to actionable insights and competitive advantage. Acquire a thorough understanding...
-
Product Insights
NewSodium Channel Protein Type 10 Subunit Alpha – Drugs In Development, 2024
The Sodium Channel Protein Type 10 Subunit Alpha pipeline drugs market research report outlays comprehensive information on the Sodium Channel Protein Type 10 Subunit Alpha targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Toxicology, Genetic Disorders, and Gastrointestinal which include indications of Post-Operative Pain, Pain, Chemotherapy Induced Peripheral Neuropathy, Genetic Disorders, Erythromelalgia, and Oral...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Solid Tumor Drug Details: SOF-10 (RG6440) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – SOF-10 in Gastric Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - SOF-10 in Gastric Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. SOF-10 in Gastric Cancer Drug Details: SOF-10 (RG6440) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TT-10 in Ovarian Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Ovarian Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TT-10 in Ovarian Cancer Drug Details: PORT-6 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – TT-10 in Colorectal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - TT-10 in Colorectal Cancer report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. TT-10 in Colorectal Cancer Drug Details: PORT-6 is under development for the...